ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,867Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 326

$1.5M Total Retail Price of All Prescriptions

Rank: 3 out of 326

836 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 836 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 836 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 24,431 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $104 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 982 882 1 2
LEVOTHYROXINE SODIUM 867 807 2 4
LISINOPRIL 770 707 3 3
HYDROCODONE-ACETAMINOPHEN 753 605 S3 4 1
WARFARIN SODIUM 682 605 5 11
FUROSEMIDE 679 634 6 7
POTASSIUM CHLORIDE 655 610 7 21
TRAMADOL HCL 640 572 8 28
CITALOPRAM HBR 622 544 9 25
OMEPRAZOLE 589 515 10 5
HYDRALAZINE HCL 567 553 11 48
METOPROLOL TARTRATE 566 524 12 6
DONEPEZIL HCL 565 556 13 34
CARVEDILOL 558 508 14 12
BUMETANIDE 497 483 15 92
FAMOTIDINE 461 441 16 107
NAMENDA 437 437 17 49
AMLODIPINE BESYLATE 406 374 18 8
FENTANYL 370 341 S2 19 47
SERTRALINE HCL 356 345 20 35
ATORVASTATIN CALCIUM 333 304 21 10
GABAPENTIN 291 206 22 17
METOPROLOL SUCCINATE 278 260 23 9
TAMSULOSIN HCL 266 246 24 29
KLOR-CON M20 261 239 25 114
DIVALPROEX SODIUM 260 194 26 116
CLOPIDOGREL 243 226 27 23
LOSARTAN POTASSIUM 236 227 28 14
DIGOXIN 229 219 29 45
MIRTAZAPINE 225 220 30 93
METFORMIN HCL 205 187 31 16
PREDNISONE 203 191 32 18
ESCITALOPRAM OXALATE 196 156 33 82
ZOLPIDEM TARTRATE 192 164 34 30
QUETIAPINE FUMARATE 191 175 35 69
TRAZODONE HCL 190 186 36 64
GLIPIZIDE 190 189 36 106
LANTUS 182 159 38 56
ALENDRONATE SODIUM 179 167 39 41
LOVASTATIN 178 150 40 46
RISPERIDONE 165 140 41 51
CLONIDINE HCL 164 151 42 74
NOVOLOG 156 144 43 123
ROPINIROLE HCL 152 144 44 152
PLAVIX 149 146 45 39
POLYETHYLENE GLYCOL 3350 143 141 46 84
CARBIDOPA-LEVODOPA 142 142 47 58
HYDROCHLOROTHIAZIDE 139 122 48 24
PHENYTOIN SODIUM EXTENDED 138 88 49 233
LEVEMIR 129 118 50 241
ALLOPURINOL 129 124 50 44
ATENOLOL 122 118 52 13
LANTUS SOLOSTAR 114 108 53 59
LISINOPRIL-HYDROCHLOROTHIAZIDE 113 99 54 57
ADVAIR DISKUS 112 111 55 80
OLANZAPINE 110 109 56 132
ISOSORBIDE MONONITRATE ER 106 101 57 19
FLUTICASONE PROPIONATE 104 93 58 22
OXYBUTYNIN CHLORIDE ER 102 84 59 203
LEVETIRACETAM 101 80 60 50
DIOVAN 100 100 61 119
IPRATROPIUM-ALBUTEROL 99 97 62 214
FINASTERIDE 99 99 62 83
GLIMEPIRIDE 98 98 64 77
NOVOLIN N 93 93 65 268
SULFAMETHOXAZOLE-TRIMETHOPRIM 92 84 66 112
AZITHROMYCIN 92 83 66 54
PANTOPRAZOLE SODIUM 87 85 68 66
IPRATROPIUM BROMIDE 85 85 69 183
BACLOFEN 85 66 69 121
JANTOVEN 84 82 71 179
SEROQUEL 84 76 71 151
OXYCODONE-ACETAMINOPHEN 81 69 S2 73 202
RAMIPRIL 80 76 74 285
LATANOPROST 80 80 74 15
ALBUTEROL SULFATE 77 76 76 147
CYMBALTA 77 56 76 61
KLOR-CON M10 76 73 78 289
GEMFIBROZIL 75 68 79 218
ENALAPRIL MALEATE 75 67 79 65
TIMOLOL MALEATE 74 74 81 32
PRAVASTATIN SODIUM 74 65 81 20
AMOX TR-POTASSIUM CLAVULANATE 73 57 83 211
LAMOTRIGINE 73 73 83 91
SPIRIVA 73 69 83 129
DETROL LA 71 62 86 208
NITROGLYCERIN PATCH 71 68 86 244
NIFEDIPINE ER 70 64 88 122
MORPHINE SULFATE ER 67 65 S2 89 38
METOLAZONE 66 61 90 193
CLOZAPINE 65 65 91 176
SPIRONOLACTONE 65 53 91 42
CARBAMAZEPINE 63 19 93 172
NYSTATIN 62 55 94 251
LACTULOSE 61 59 95 144
VENLAFAXINE HCL ER 60 60 96 155
CEFTRIAXONE 57 53 97 256
CLONIDINE 57 56 97 325
PROAIR HFA 56 43 99 100
INSULIN SYRINGE 56 44 99 128
HUMULIN N 53 53 101 342
DILTIAZEM 24HR CD 53 51 101 127
TRIAMTERENE-HCTZ 52 47 103 72
BUSPIRONE HCL 52 52 103 166
GLYBURIDE 51 48 R 105 117
TRAVATAN Z 51 51 105 60
FORTICAL 51 51 105 350
NIFEDICAL XL 50 50 108 354
CIPROFLOXACIN HCL 50 49 108 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.